Rua Bioscience Limited (NZE:RUA)

Market Cap	13.92M +32.4%
Revenue (ttm)	2.39M +124.8%
Net Income	-3.45M
EPS	-0.01
Shares Out	339.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,146
Open	0.0410
Previous Close	0.0410
Day's Range	0.0410 - 0.0410
52-Week Range	0.0260 - 0.0590
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in seed production and genetic discovery related activities. In addition, it engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In fiscal year 2025, Rua Bioscience's revenue was 1.83 million, an increase of 477.39% compared to the previous year's 316,350. Losses were -3.46 million, -74.81% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 3, 2026

Data Sources Report a data error